Logotype for Metrovacesa S.A.

Metrovacesa (MVC) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Metrovacesa S.A.

Q2 2024 earnings summary

29 Sep, 2026

Executive summary

  • Revenues rose 42% year-over-year to €235 million in H1 2024, with EBITDA up 223% to €31.3 million and net profit at €3.8 million, reversing a loss from H1 2023.

  • Delivered 675 homes (+18% YoY) at an average price of €335,000, with gross margin at 24.2% and record pre-sales of 1,046 units (+15% YoY).

  • Sales backlog reached €1.2 billion, with 3,703 units and high contract formalization rates, providing strong visibility for future cash flows.

  • ESG initiatives advanced, with all launches achieving AA energy efficiency and comprehensive life cycle carbon analysis underway.

  • Land sales pipeline grew to €58 million in binding contracts, and land purchases reached €23.4 million in H1 2024.

Financial highlights

  • H1 2024 revenues of €235 million (+42% YoY), with residential contributing €226.7 million and land sales €8.3 million.

  • EBITDA reached €31.3 million (+223% YoY); recurring pre-tax profit at €22.4 million; net profit was €3.8 million, up from a loss in H1 2023.

  • Gross margin improved to 24.2%, the highest since 2018; net margin at 19.4%.

  • Free cash flow of €66.2 million (+150% YoY); net debt at €343.4 million with a 13.8% loan-to-value ratio.

  • Average selling price rose to €335,000 per unit, up 17% year-over-year.

Outlook and guidance

  • On track to deliver more units in 2024 than in 2023, with a higher concentration of deliveries in H2.

  • Sales coverage for 2025 at 73% and for 2026 at 50%, supporting strong visibility.

  • Cash flow generation guidance reiterated at €100–125 million for the year.

  • Gross margin guidance raised to 22–23% for the coming years.

  • Positive market prospects expected to continue, with further support from potential ECB rate cuts.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Metrovacesa